Clinical phenotype of <scp>COVID</scp>‐19 vaccine‐associated myocarditis in Victoria, 2021–22: a cross‐sectional study
The clinical severity of COVID-19 vaccine-associated myocarditis in Victoria was generally mild. Markers of a more severe phenotype were more frequently recorded for male patients and people aged 24 years or younger. A threefold troponin increase could be used as a threshold for risk stratification of people with COVID-19 vaccine-associated myocarditis, especially in hospitals with limited access to cMRI facilities.
Authors
- Nicholas Cox (ORCID: https://orcid.org/0000-0001-7442-2829)
- Nigel W. Crawford (ORCID: https://orcid.org/0000-0003-1851-5080)
- James Hare (ORCID: https://orcid.org/0000-0001-6438-1867)
- Jim Buttery (ORCID: https://orcid.org/0000-0001-9905-2035)
- Daryl R. Cheng (ORCID: https://orcid.org/0000-0001-5455-957X)
- Hannah Morgan (ORCID: https://orcid.org/0000-0001-8717-908X)
- Silja Schrader (ORCID: https://orcid.org/0000-0003-1776-6152)
- Hazel J Clothier (ORCID: https://orcid.org/0000-0001-7594-0361)
- Andrew J. Taylor (ORCID: https://orcid.org/0000-0001-8920-7670)
- Annette Alafaci
- Priya Shenton (ORCID: https://orcid.org/0000-0001-9956-7311)
- Julia Smith (ORCID: https://orcid.org/0000-0002-5175-1109)
- Bryn Jones (ORCID: https://orcid.org/0000-0002-3554-9808)
Institutions
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- The Alfred Hospital (AU)
- Footscray Hospital (AU)
- Murdoch Children's Research Institute (AU)
- Alfred Health (AU)
Publication Details
- Journal
- The Medical Journal of Australia
- Published
- 2024-12-10
- DOI
- https://doi.org/10.5694/mja2.52557
- Citations
- 2
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.80